$ELTP Recent News Former CEO of Elite Pharmace
Post# of 94146
Posted On: 12/05/2014 11:17:31 AM
$ELTP Recent News
Former CEO of Elite Pharmaceuticals sells all shares 9:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:27 p.m. Aug. 8, 2003 - Chris Kraeuter
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript 5:49 p.m. Nov. 19, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:28 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
InsiderInsights.com Daily Round Up 9/29/14: AGCO, UVSP, OPK, RSG 11:03 p.m. Sept. 30, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakimon on Q1FY2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 3:17 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript 3:25 p.m. July 1, 2014 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:57 p.m. June 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 8:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 8:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 10:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 11:01 p.m. May 9, 2013 - InvestorPlace.com
Racket of Their Own 11:01 p.m. Aug. 14, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 11:01 p.m. Sept. 3, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 5:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 12:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse-Deterrent Oxycodone Product ELI-201 9:56 a.m. Dec. 3, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015 6:25 p.m. Nov. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014 5:03 p.m. Nov. 13, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces New Management Appointments 6:16 a.m. Oct. 24, 2014 - GlobeNewswire
Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data for ELI-200, an Opioid Abuse Deterrent Product 6:01 a.m. Sept. 9, 2014 - GlobeNewswire
Elite Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 12:48 p.m. Sept. 3, 2014 - GlobeNewswire
OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc. 10:09 a.m. Aug. 19, 2014 - PR Newswire - PRF
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 3:15 p.m. Aug. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 6:11 a.m. Aug. 13, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201 9:32 a.m. July 15, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014 1:07 p.m. June 30, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014 9:35 a.m. June 26, 2014 - GlobeNewswire
Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement With Novel Laboratories 10:11 a.m. June 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200 7:01 a.m. June 9, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces Results of 2014 Annual Meeting of Shareholders 10:10 a.m. May 23, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product 7:16 a.m. May 19, 2014 - GlobeNewswire
Elite Pharmaceuticals Showing Long Term Promise, Analyst Report by BrokerBank Securities, Inc. 6:30 a.m. May 5, 2014 - PR Newswire - PRF
FDA Approves Clinical Trial of BrainStorm Cell Therapeutics' ALS Treatment 9:06 a.m. April 29, 2014 - ACCESSWIRE
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 6:43 a.m. April 22, 2014 - GlobeNewswire
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 9:08 a.m. April 16, 2014 - ACCESSWIRE
Former CEO of Elite Pharmaceuticals sells all shares 9:47 a.m. Oct. 28, 2004 - James Comtois
Semel's Yahoo stock sales lead weekly insider trades 3:17 p.m. Oct. 25, 2004 - James Comtois
Elite Pharma says ends Nostrum Pharma merger talks 4:19 p.m. Aug. 6, 2004 - Carla Mozee
Elite Pharmaceuticals settles w/former CEO 11:07 a.m. May 3, 2004 - Maggie McNeil
Elite settles w/former CEO, includes $400,000 payment 12:15 p.m. April 1, 2004 - Maggie McNeil
Elite Pharma to negotiate purchase of Nostrum 1:27 p.m. Aug. 8, 2003 - Chris Kraeuter
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q2 2015 Results - Earnings Call Transcript 5:49 p.m. Nov. 19, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 4:28 p.m. Nov. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
InsiderInsights.com Daily Round Up 9/29/14: AGCO, UVSP, OPK, RSG 11:03 p.m. Sept. 30, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1 2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q1FY2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakimon on Q1FY2015 Results - Earnings Call Transcript 4:12 p.m. Aug. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 3:17 p.m. Aug. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' (ELTP) CEO Nasrat Hakim on Q4 2014 Results - Earnings Call Transcript 3:25 p.m. July 1, 2014 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:57 p.m. June 30, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals' CEO Discusses F3Q2014 Results - Earnings Call Transcript 8:19 p.m. Feb. 18, 2014 - Seeking Alpha
10-Q: ELITE PHARMACEUTICALS INC /NV/ 8:08 a.m. Feb. 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
Elite Pharmaceuticals: Swinging For The Fences 10:53 a.m. Dec. 18, 2013 - Seeking Alpha
10-K: ELITE PHARMACEUTICALS INC /NV/ 12:10 p.m. June 21, 2013 - Edgar Online - (EDG = 10Q, 10K)
1 Stock to Buy, 1 Stock to Short: Pharmaceuticals 11:01 p.m. May 9, 2013 - InvestorPlace.com
Racket of Their Own 11:01 p.m. Aug. 14, 2006 - The Wall Street Journal Interactive Edition
Bristol Nears Approval on New Drug 11:01 p.m. Sept. 3, 2002 - The Wall Street Journal Interactive Edition
Market Movers Sink in First Half 5:32 p.m. July 1, 2002 - The Wall Street Journal Interactive Edition
Arthritis War Set to Commence 12:37 a.m. Nov. 10, 1998 - The Wall Street Journal Interactive Edition
Elite Pharmaceuticals Reports Successful Pivotal Bioequivalence Study for Abuse-Deterrent Oxycodone Product ELI-201 9:56 a.m. Dec. 3, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Second Quarter of Fiscal Year 2015 6:25 p.m. Nov. 18, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on Wednesday, November 19, 2014 5:03 p.m. Nov. 13, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces New Management Appointments 6:16 a.m. Oct. 24, 2014 - GlobeNewswire
Elite Pharmaceuticals Releases Positive Top Line Human Abuse Liability Data for ELI-200, an Opioid Abuse Deterrent Product 6:01 a.m. Sept. 9, 2014 - GlobeNewswire
Elite Pharmaceuticals to Present at the 16th Annual Rodman & Renshaw Global Investment Conference in New York City September 8-10th 12:48 p.m. Sept. 3, 2014 - GlobeNewswire
OTC Daily Trading News: Evoq Properties, Inc. MedBox, Inc. LabStyle Innovations Corp, MyEcheck, Inc. Elite Pharmaceuticals, Inc. 10:09 a.m. Aug. 19, 2014 - PR Newswire - PRF
Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2015 3:15 p.m. Aug. 14, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host Quarterly Business Update Call on August 18, 2014 6:11 a.m. Aug. 13, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for ELI-201 9:32 a.m. July 15, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2014 1:07 p.m. June 30, 2014 - GlobeNewswire
Elite Pharmaceuticals, Inc. to Host 2014 Fiscal Year End Conference Call on Tuesday, July 1, 2014 9:35 a.m. June 26, 2014 - GlobeNewswire
Elite Pharmaceuticals Enters Into $5 Million Settlement Agreement With Novel Laboratories 10:11 a.m. June 10, 2014 - GlobeNewswire
Elite Pharmaceuticals Begins Human Abuse Liability Studies for ELI-200 7:01 a.m. June 9, 2014 - GlobeNewswire
Elite Pharmaceuticals Announces Results of 2014 Annual Meeting of Shareholders 10:10 a.m. May 23, 2014 - GlobeNewswire
Elite Pharmaceuticals Initiates Pivotal Bioequivalence Study for Third Opioid Abuse Deterrent Product 7:16 a.m. May 19, 2014 - GlobeNewswire
Elite Pharmaceuticals Showing Long Term Promise, Analyst Report by BrokerBank Securities, Inc. 6:30 a.m. May 5, 2014 - PR Newswire - PRF
FDA Approves Clinical Trial of BrainStorm Cell Therapeutics' ALS Treatment 9:06 a.m. April 29, 2014 - ACCESSWIRE
Elite Pharmaceuticals Granted New Patent for Abuse Deterrent Technology 6:43 a.m. April 22, 2014 - GlobeNewswire
Limitless Venture Group Settles $163,391 Note with Beaufort Capital Partners 9:08 a.m. April 16, 2014 - ACCESSWIRE
(0)
(0)Scroll down for more posts ▼